Electromed ROA 2010-2023 | ELMD
Current and historical return on assets (ROA) values for Electromed (ELMD) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Electromed ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-12-31 | $0.00B | $0.05B | 8.89% |
| 2023-09-30 | $0.00B | $0.04B | 6.90% |
| 2023-06-30 | $0.00B | $0.05B | 7.06% |
| 2023-03-31 | $0.00B | $0.04B | 4.85% |
| 2022-12-31 | $0.00B | $0.04B | 4.97% |
| 2022-09-30 | $0.00B | $0.04B | 5.06% |
| 2022-06-30 | $0.00B | $0.04B | 5.13% |
| 2022-03-31 | $0.00B | $0.04B | 5.26% |
| 2021-12-31 | $0.00B | $0.04B | 2.67% |
| 2021-09-30 | $0.00B | $0.04B | 2.70% |
| 2021-06-30 | $0.00B | $0.04B | 5.56% |
| 2021-03-31 | $0.00B | $0.04B | 8.57% |
| 2020-12-31 | $0.00B | $0.04B | 11.76% |
| 2020-09-30 | $0.00B | $0.03B | 12.21% |
| 2020-06-30 | $0.00B | $0.03B | 12.60% |
| 2020-03-31 | $0.00B | $0.03B | 13.01% |
| 2019-12-31 | $0.00B | $0.03B | 10.17% |
| 2019-09-30 | $0.00B | $0.03B | 7.02% |
| 2019-06-30 | $0.00B | $0.03B | 3.57% |
| 2019-03-31 | $0.00B | $0.03B | 3.64% |
| 2018-12-31 | $0.00B | $0.03B | 3.77% |
| 2018-09-30 | $0.00B | $0.03B | 3.88% |
| 2018-06-30 | $0.00B | $0.03B | 4.08% |
| 2018-03-31 | $0.00B | $0.02B | 4.26% |
| 2017-12-31 | $0.00B | $0.02B | 8.70% |
| 2017-09-30 | $0.00B | $0.02B | 8.99% |
| 2017-06-30 | $0.00B | $0.02B | 9.30% |
| 2017-03-31 | $0.00B | $0.02B | 4.76% |
| 2016-12-31 | $0.00B | $0.02B | 0.00% |
| 2016-09-30 | $0.00B | $0.02B | 5.00% |
| 2016-06-30 | $0.00B | $0.02B | 5.13% |
| 2016-03-31 | $0.00B | $0.02B | 5.41% |
| 2015-12-31 | $0.00B | $0.02B | 5.63% |
| 2015-09-30 | $0.00B | $0.02B | 0.00% |
| 2015-06-30 | $0.00B | $0.02B | 0.00% |
| 2015-03-31 | $0.00B | $0.02B | 0.00% |
| 2014-12-31 | $-0.00B | $0.02B | -6.06% |
| 2014-09-30 | $-0.00B | $0.02B | -6.06% |
| 2014-06-30 | $-0.00B | $0.02B | -6.06% |
| 2014-03-31 | $-0.00B | $0.02B | -5.88% |
| 2013-12-31 | $0.00B | $0.02B | 0.00% |
| 2013-09-30 | $0.00B | $0.02B | 0.00% |
| 2013-06-30 | $0.00B | $0.02B | 0.00% |
| 2013-03-31 | $0.00B | $0.02B | 0.00% |
| 2012-12-31 | $0.00B | $0.02B | 0.00% |
| 2012-09-30 | $0.00B | $0.02B | 0.00% |
| 2012-06-30 | $0.00B | $0.02B | 0.00% |
| 2012-03-31 | $0.00B | $0.02B | 0.00% |
| 2011-12-31 | $0.00B | $0.02B | 0.00% |
| 2011-09-30 | $0.00B | $0.02B | 0.00% |
| 2011-06-30 | $0.00B | $0.02B | 0.00% |
| 2011-03-31 | $0.00B | $0.02B | 0.00% |
| 2010-12-31 | $0.00B | $0.02B | 0.00% |
| 2010-09-30 | $0.00B | $0.02B | 0.00% |
| 2010-06-30 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.120B | $0.048B |
| Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest? Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company's products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $206.706B | 25.14 |
| Intuitive Surgical (ISRG) | United States | $132.078B | 79.62 |
| Edwards Lifesciences (EW) | United States | $52.037B | 34.44 |
| DexCom (DXCM) | United States | $51.775B | 88.94 |
| IQVIA Holdings (IQV) | United States | $41.231B | 24.45 |
| IDEXX Laboratories (IDXX) | United States | $39.682B | 47.45 |
| Alcon (ALC) | Switzerland | $38.694B | 28.53 |
| STERIS (STE) | Ireland | $19.843B | 23.49 |
| Hologic (HOLX) | United States | $17.628B | 19.46 |
| Waters (WAT) | United States | $17.451B | 25.04 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.168B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.248B | 84.63 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.379B | 14.05 |
| Sysmex ADR (SSMXY) | Japan | $9.881B | 30.99 |
| Teleflex (TFX) | United States | $9.768B | 15.34 |
| Penumbra (PEN) | United States | $7.812B | 96.57 |
| Masimo (MASI) | United States | $7.192B | 40.33 |
| Globus Medical (GMED) | United States | $6.870B | 21.78 |
| Glaukos (GKOS) | United States | $4.774B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.948B | 25.23 |
| TransMedics (TMDX) | United States | $2.854B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.847B | 18.78 |
| PROCEPT BioRobotics (PRCT) | United States | $2.603B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.599B | 17.83 |
| Integra LifeSciences Holdings (IART) | United States | $2.486B | 10.20 |
| Nihon Kohden (NHNKY) | Japan | $2.315B | 19.58 |
| Inari Medical (NARI) | United States | $2.240B | 386.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.997B | 0.00 |
| RxSight (RXST) | United States | $1.914B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.703B | 0.00 |
| Veracyte (VCYT) | United States | $1.441B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.864B | 15.98 |
| OPKO Health (OPK) | United States | $0.857B | 0.00 |
| Artivion (AORT) | United States | $0.833B | 96.24 |
| Paragon 28 (FNA) | United States | $0.800B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.701B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.696B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.682B | 0.00 |
| SiBone (SIBN) | United States | $0.628B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.537B | 18.25 |
| IRadimed (IRMD) | United States | $0.511B | 29.68 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Nevro (NVRO) | United States | $0.452B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.391B | 0.00 |
| NeuroPace (NPCE) | United States | $0.368B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 11.31 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| AxoGen (AXGN) | United States | $0.286B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.260B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.245B | 0.00 |
| Accuray (ARAY) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
| 908 Devices (MASS) | United States | $0.184B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.179B | 9.64 |
| Atossa Genetics (ATOS) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.146B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.119B | 0.00 |
| Neuronetics (STIM) | United States | $0.115B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.100B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.094B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Vasomedical (VASO) | United States | $0.056B | 9.99 |
| Autonomix Medical (AMIX) | United States | $0.054B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 108.33 |
| InspireMD (NSPR) | Israel | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.044B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |